wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38604100-21EC4593-97F6-41F6-915F-3B73101871A1
Q38604100-21EC4593-97F6-41F6-915F-3B73101871A1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38604100-21EC4593-97F6-41F6-915F-3B73101871A1
Opportunities and challenges for the cellular immunotherapy sector: a global landscape of clinical trials.
P2860
Q38604100-21EC4593-97F6-41F6-915F-3B73101871A1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38604100-21EC4593-97F6-41F6-915F-3B73101871A1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4f0b1bd81a5bfba9c905282f7823a2b5f5686f8e
P2860
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.